Medacta Group S.A.
MEDGF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $344,140 | $301,931 | $288,649 | $255,637 |
| % Growth | 14% | 4.6% | 12.9% | – |
| Cost of Goods Sold | $109,018 | $100,230 | $90,911 | $83,656 |
| Gross Profit | $235,122 | $201,701 | $197,738 | $171,981 |
| % Margin | 68.3% | 66.8% | 68.5% | 67.3% |
| R&D Expenses | $11,663 | $11,121 | $10,271 | $10,728 |
| G&A Expenses | $44,827 | $39,067 | $36,529 | $31,831 |
| SG&A Expenses | $163,116 | $143,948 | $142,197 | $129,045 |
| Sales & Mktg Exp. | $118,289 | $104,881 | $105,668 | $97,214 |
| Other Operating Expenses | -$13,703 | $15,039 | $2,420 | $720 |
| Operating Expenses | $161,076 | $170,108 | $154,888 | $140,493 |
| Operating Income | $74,046 | $31,593 | $42,850 | $31,488 |
| % Margin | 21.5% | 10.5% | 14.8% | 12.3% |
| Other Income/Exp. Net | -$5,443 | $11,512 | $1,814 | -$8,962 |
| Pre-Tax Income | $68,603 | $43,105 | $44,664 | $22,526 |
| Tax Expense | $8,564 | $8,211 | $6,672 | $4,307 |
| Net Income | $60,039 | $34,894 | $37,992 | $18,219 |
| % Margin | 17.4% | 11.6% | 13.2% | 7.1% |
| EPS | 3.01 | 1.76 | 1.9 | 0.91 |
| % Growth | 71% | -7.4% | 108.8% | – |
| EPS Diluted | 3.01 | 1.76 | 1.9 | 0.91 |
| Weighted Avg Shares Out | 19,947 | 19,938 | 19,996 | 20,020 |
| Weighted Avg Shares Out Dil | 19,955 | 19,967 | 19,944 | 19,993 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $28 |
| Interest Expense | $5,443 | $9,105 | $0 | $0 |
| Depreciation & Amortization | $36,408 | $17,265 | $31,987 | $15,004 |
| EBITDA | $97,003 | $64,665 | $77,524 | $48,224 |
| % Margin | 28.2% | 21.4% | 26.9% | 18.9% |